HK Stock MarketDetailed Quotes

01093 CSPC PHARMA

Watchlist
  • 4.800
  • +0.080+1.69%
Trading Aug 26 10:47 CST
56.93BMarket Cap8.76P/E (TTM)

CSPC PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Turnover
1.27%16.28B
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
16.94%7.87B
Operating income
1.27%16.28B
11.54%8.98B
1.66%31.45B
1.57%23.87B
3.01%16.08B
2.28%8.05B
11.02%30.94B
13.83%23.5B
12.93%15.61B
16.94%7.87B
Cost of sales
4.40%-4.63B
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
-33.14%-2.06B
Operating expenses
4.40%-4.63B
1.87%-2.49B
-6.83%-9.27B
-10.29%-7.07B
-13.37%-4.84B
-22.87%-2.53B
-28.95%-8.68B
-28.62%-6.41B
-29.53%-4.27B
-33.14%-2.06B
Gross profit
3.71%11.65B
17.70%6.5B
-0.36%22.18B
-1.70%16.79B
-0.89%11.24B
-5.03%5.52B
5.31%22.26B
9.11%17.08B
7.73%11.34B
12.09%5.81B
Selling expenses
2.55%-4.78B
-18.97%-2.96B
11.58%-9.14B
13.34%-7.03B
9.39%-4.9B
11.91%-2.49B
1.01%-10.34B
-4.32%-8.11B
-1.69%-5.41B
-7.77%-2.82B
Administrative expenses
-18.15%-632.84M
-26.51%-332.83M
-1.43%-1.19B
2.08%-855.97M
5.17%-535.64M
-1.07%-263.08M
-16.14%-1.17B
-16.82%-874.16M
-13.64%-564.82M
-20.08%-260.3M
Research and development expenses
-10.35%-2.54B
-16.04%-1.17B
-21.17%-4.83B
-25.95%-3.68B
-22.27%-2.3B
-11.77%-1.01B
-16.14%-3.99B
-16.43%-2.92B
-16.81%-1.88B
-30.41%-901.52M
Special items of operating profit
-19.70%172.47M
41.09%59.06M
-48.38%420.59M
-8.36%405.88M
-13.72%214.78M
164.60%41.86M
49.32%814.85M
-22.03%442.91M
-54.52%248.93M
-148.06%-64.8M
Operating profit
4.42%3.87B
16.13%2.09B
-1.82%7.44B
0.27%5.63B
-0.47%3.71B
2.37%1.8B
11.47%7.57B
8.24%5.62B
2.38%3.73B
-1.68%1.76B
Financing cost
-104.95%-21.98M
-37.84%-6.11M
-4.04%-25.9M
-12.51%-16.88M
-10.29%-10.72M
-54.97%-4.43M
-224.78%-24.89M
-132.70%-15M
-103.22%-9.72M
-0.88%-2.86M
Share of profits of associates
-67.65%-27.24M
-24.61%-15.01M
3.40%-41.07M
29.06%-32.97M
39.72%-16.25M
-42.31%-12.05M
-77.91%-42.51M
-119.94%-46.48M
-38.43%-26.95M
38.39%-8.46M
Share of profit from joint venture company
-983.37%-24.43M
-187.38%-13.48M
-148.43%-13.13M
-113.24%-5.5M
-108.12%-2.26M
-131.76%-4.69M
-41.49%27.11M
15.51%41.56M
32.14%27.78M
46.54%14.77M
Special items of earning before tax
----
----
-31.63%32.86M
--32.86M
----
----
28.64%48.07M
----
----
----
Earning before tax
3.25%3.8B
15.57%2.06B
-2.54%7.39B
0.23%5.61B
-1.02%3.68B
0.97%1.78B
10.74%7.58B
7.18%5.6B
1.54%3.72B
-1.13%1.76B
Tax
-20.23%-749.66M
-37.35%-428.35M
2.48%-1.32B
5.98%-964.74M
9.95%-623.51M
5.39%-311.86M
-16.50%-1.35B
-24.40%-1.03B
-25.03%-692.38M
-15.08%-329.63M
After-tax profit from continuing operations
-0.21%3.05B
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
-4.23%1.43B
Earning after tax
-0.21%3.05B
10.94%1.63B
-2.56%6.07B
1.62%4.65B
1.02%3.06B
2.43%1.47B
9.56%6.23B
3.95%4.57B
-2.64%3.03B
-4.23%1.43B
Minority profit
-65.85%31.09M
-57.68%17.04M
41.74%199.37M
45.84%150.38M
49.57%91.05M
35.22%40.26M
69.59%140.66M
66.96%103.11M
30.80%60.88M
14.11%29.77M
Profit attributable to shareholders
1.80%3.02B
12.88%1.61B
-3.58%5.87B
0.60%4.49B
0.03%2.97B
1.73%1.43B
8.67%6.09B
3.06%4.47B
-3.15%2.97B
-4.55%1.4B
Basic earnings per share
2.24%0.2551
13.51%0.1361
-3.21%0.4947
0.93%0.3784
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
-4.07%0.1179
Diluted earnings per share
2.24%0.2551
13.51%0.1361
-3.21%0.4947
0.91%0.3783
0.24%0.2495
1.70%0.1199
9.00%0.5111
3.39%0.3749
-2.85%0.2489
-4.07%0.1179
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Auditor
--
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
--
--
Deloitte - Guan Huang Chen Fang Certified Public Accountants
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Turnover 1.27%16.28B11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B16.94%7.87B
Operating income 1.27%16.28B11.54%8.98B1.66%31.45B1.57%23.87B3.01%16.08B2.28%8.05B11.02%30.94B13.83%23.5B12.93%15.61B16.94%7.87B
Cost of sales 4.40%-4.63B1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B-33.14%-2.06B
Operating expenses 4.40%-4.63B1.87%-2.49B-6.83%-9.27B-10.29%-7.07B-13.37%-4.84B-22.87%-2.53B-28.95%-8.68B-28.62%-6.41B-29.53%-4.27B-33.14%-2.06B
Gross profit 3.71%11.65B17.70%6.5B-0.36%22.18B-1.70%16.79B-0.89%11.24B-5.03%5.52B5.31%22.26B9.11%17.08B7.73%11.34B12.09%5.81B
Selling expenses 2.55%-4.78B-18.97%-2.96B11.58%-9.14B13.34%-7.03B9.39%-4.9B11.91%-2.49B1.01%-10.34B-4.32%-8.11B-1.69%-5.41B-7.77%-2.82B
Administrative expenses -18.15%-632.84M-26.51%-332.83M-1.43%-1.19B2.08%-855.97M5.17%-535.64M-1.07%-263.08M-16.14%-1.17B-16.82%-874.16M-13.64%-564.82M-20.08%-260.3M
Research and development expenses -10.35%-2.54B-16.04%-1.17B-21.17%-4.83B-25.95%-3.68B-22.27%-2.3B-11.77%-1.01B-16.14%-3.99B-16.43%-2.92B-16.81%-1.88B-30.41%-901.52M
Special items of operating profit -19.70%172.47M41.09%59.06M-48.38%420.59M-8.36%405.88M-13.72%214.78M164.60%41.86M49.32%814.85M-22.03%442.91M-54.52%248.93M-148.06%-64.8M
Operating profit 4.42%3.87B16.13%2.09B-1.82%7.44B0.27%5.63B-0.47%3.71B2.37%1.8B11.47%7.57B8.24%5.62B2.38%3.73B-1.68%1.76B
Financing cost -104.95%-21.98M-37.84%-6.11M-4.04%-25.9M-12.51%-16.88M-10.29%-10.72M-54.97%-4.43M-224.78%-24.89M-132.70%-15M-103.22%-9.72M-0.88%-2.86M
Share of profits of associates -67.65%-27.24M-24.61%-15.01M3.40%-41.07M29.06%-32.97M39.72%-16.25M-42.31%-12.05M-77.91%-42.51M-119.94%-46.48M-38.43%-26.95M38.39%-8.46M
Share of profit from joint venture company -983.37%-24.43M-187.38%-13.48M-148.43%-13.13M-113.24%-5.5M-108.12%-2.26M-131.76%-4.69M-41.49%27.11M15.51%41.56M32.14%27.78M46.54%14.77M
Special items of earning before tax ---------31.63%32.86M--32.86M--------28.64%48.07M------------
Earning before tax 3.25%3.8B15.57%2.06B-2.54%7.39B0.23%5.61B-1.02%3.68B0.97%1.78B10.74%7.58B7.18%5.6B1.54%3.72B-1.13%1.76B
Tax -20.23%-749.66M-37.35%-428.35M2.48%-1.32B5.98%-964.74M9.95%-623.51M5.39%-311.86M-16.50%-1.35B-24.40%-1.03B-25.03%-692.38M-15.08%-329.63M
After-tax profit from continuing operations -0.21%3.05B10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B-4.23%1.43B
Earning after tax -0.21%3.05B10.94%1.63B-2.56%6.07B1.62%4.65B1.02%3.06B2.43%1.47B9.56%6.23B3.95%4.57B-2.64%3.03B-4.23%1.43B
Minority profit -65.85%31.09M-57.68%17.04M41.74%199.37M45.84%150.38M49.57%91.05M35.22%40.26M69.59%140.66M66.96%103.11M30.80%60.88M14.11%29.77M
Profit attributable to shareholders 1.80%3.02B12.88%1.61B-3.58%5.87B0.60%4.49B0.03%2.97B1.73%1.43B8.67%6.09B3.06%4.47B-3.15%2.97B-4.55%1.4B
Basic earnings per share 2.24%0.255113.51%0.1361-3.21%0.49470.93%0.37840.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489-4.07%0.1179
Diluted earnings per share 2.24%0.255113.51%0.1361-3.21%0.49470.91%0.37830.24%0.24951.70%0.11999.00%0.51113.39%0.3749-2.85%0.2489-4.07%0.1179
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions ----Unqualified Opinion------Unqualified Opinion------
Auditor ----Deloitte - Guan Huang Chen Fang Certified Public Accountants------Deloitte - Guan Huang Chen Fang Certified Public Accountants------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg